PAM50 date from 3689 HER2-low and HER2 score 0 breast cancers revealed that the HER2-low tumours were predominantly of the luminal type compared with the TNBC (65.4% VS 36.6% respectively) [25]. The gene discussed is ERBB2; the disease is breast cancer.